Free Trial

Trading of Ernexa Therapeutics was halted at 11:12 AM EST due to "LULD Pause".

Ernexa Therapeutics (ERNA) Institutional Ownership

Ernexa Therapeutics logo
$11.38 +4.17 (+57.84%)
As of 03:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Ernexa Therapeutics (NASDAQ:ERNA)

Current
Institutional Ownership
Percentage
70.55%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$844.63K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$35.13M
Get ERNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ernexa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ERNA Institutional Buying and Selling by Quarter

Ernexa Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Susquehanna International Group LLP30,854$34K0.0%N/A0.393%
9/26/2025Corient Private Wealth LLC17,523$32K0.0%-93.3%0.228%
8/15/2025Corient Private Wealth LLC17,523$32K0.0%-93.3%0.228%
8/8/2025Geode Capital Management LLC20,075$37K0.0%-93.2%0.273%
2/12/2025Geode Capital Management LLC257,310$76K0.0%+1,159.2%4.756%
5/3/2024Avidian Wealth Solutions LLC14,798$36K0.0%N/A0.274%
5/2/2024Sippican Capital Advisors72,800$175K0.1%+34.7%1.346%
2/13/2024Lake Street Advisors Group LLC520,996$933K0.1%N/A9.630%
1/30/2024Sippican Capital Advisors54,050$97K0.1%+92.3%0.999%
1/1/2024Vanguard Group Inc.24,898$54K0.0%+30.6%0.460%
10/24/2023Sippican Capital Advisors28,100$61K0.1%+30.1%0.519%
2/1/2023Cypress Point Wealth Management LLC94,375$304K0.5%N/A3.210%
1/31/2023Naviter Wealth LLC79,621$387K0.1%N/A2.708%


ERNA Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Ernexa Therapeutics shares: Geode Capital Management LLC ($37K), and Susquehanna International Group LLP ($34K), Corient Private Wealth LLC ($32K).Learn more on Ernexa Therapeutics' institutional investors.

70.55% of Ernexa Therapeutics' stock is owned by institutional investors. Learn more on ERNA's institutional investor holdings.

The following institutional investors have purchased Ernexa Therapeutics' stock in the last 24 months: Geode Capital Management LLC ($236.88K), and Susquehanna International Group LLP ($30.85K).

Institutional investors have bought a total of 30,854 shares in the last 24 months. This purchase volume represents approximately $844.63K in transactions.

The following institutional investors have sold Ernexa Therapeutics stock in the last 24 months: Corient Private Wealth LLC ($490.68K), and Geode Capital Management LLC ($273.07K).

Institutional investors have sold a total of 763,751 shares in the last 24 months. This volume of shares sold represents approximately $35.13M in transactions.



This page (NASDAQ:ERNA) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners